Nu Skin (NUS) Shares Skyrocket, What You Need To Know

StockStory
03 Jan
Nu Skin (NUS) Shares Skyrocket, What You Need To Know

What Happened?

Shares of personal care company Nu Skin (NYSE:NUS) jumped 21.9% in the morning session after the company announced the sale of the Mavely affiliate technology platform, owned by its subsidiary Rhyz Inc., to Later, a marketing and social media management software firm. Valued at $250 million, the deal delivered a substantial payoff, with management adding, "This transaction yielded roughly a fivefold return on the company's total investment in Mavely since its acquisition in 2021."

Is now the time to buy Nu Skin? Access our full analysis report here, it’s free.

What The Market Is Telling Us

Nu Skin’s shares are quite volatile and have had 19 moves greater than 5% over the last year. But moves this big are rare even for Nu Skin and indicate this news significantly impacted the market’s perception of the business. 

The biggest move we wrote about over the last year was 11 months ago when the stock dropped 27.3% on the news that the company reported weak fourth-quarter results and provided underwhelming guidance. Specifically, full-year revenue and EPS guidance missed analysts' expectations by a large amount. Next quarter's guidance was no better, with both revenue and EPS again coming in below expectations. Overall, this was a mediocre quarter for Nu Skin.

Investors who bought $1,000 worth of Nu Skin’s shares 5 years ago would now be looking at an investment worth $199.33.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10